Head-to-Head

Fennec Pharmaceuticals Inc. Common Stock vs. ImmunityBio, Inc. Common Stock

FENC

Fennec Pharmaceuticals Inc. Common Stock

$10.71 +0.75%

VS IBRX

ImmunityBio, Inc. Common Stock

$10.51 +6.05%

Fennec Pharmaceuticals Inc. Common Stock and ImmunityBio, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

FENCIBRX
Market Cap $372.76 million $11.14 billion

IBRX leads on 1 of 1 size & scale factors.

Risk & Sentiment

FENCIBRX
Short Interest 0.07% 0.42%

FENC leads on 1 of 1 risk & sentiment factors.

Dig deeper: FENC overview, FENC financials, IBRX overview, IBRX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.